- Home
- GF vs INO Comparison
GF vs INO Comparison
Compare GF & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GF
- INO
- Stock Information
- Founded
- GF 1990
- INO 1979
- Country
- GF Germany
- INO United States
- Employees
- GF N/A
- INO N/A
- Industry
- GF Investment Managers
- INO Medical/Dental Instruments
- Sector
- GF Finance
- INO Health Care
- Exchange
- GF Nasdaq
- INO Nasdaq
- Market Cap
- GF 138.1M
- INO 110.7M
- IPO Year
- GF N/A
- INO 1998
- Fundamental
- Price
- GF $7.93
- INO $1.84
- Analyst Decision
- GF
- INO Buy
- Analyst Count
- GF 0
- INO 6
- Target Price
- GF N/A
- INO $16.33
- AVG Volume (30 Days)
- GF 28.1K
- INO 1.3M
- Earning Date
- GF 01-01-0001
- INO 11-14-2024
- Dividend Yield
- GF 0.82%
- INO N/A
- EPS Growth
- GF N/A
- INO N/A
- EPS
- GF N/A
- INO N/A
- Revenue
- GF N/A
- INO $203,413.00
- Revenue This Year
- GF N/A
- INO N/A
- Revenue Next Year
- GF N/A
- INO $2,290.97
- P/E Ratio
- GF N/A
- INO N/A
- Revenue Growth
- GF N/A
- INO N/A
- 52 Week Low
- GF $7.38
- INO $1.74
- 52 Week High
- GF $9.41
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- GF 32.28
- INO 14.15
- Support Level
- GF $8.09
- INO $1.74
- Resistance Level
- GF $8.44
- INO $4.08
- Average True Range (ATR)
- GF 0.10
- INO 0.25
- MACD
- GF -0.03
- INO -0.19
- Stochastic Oscillator
- GF 7.80
- INO 3.48
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a United States-based non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.